171 related articles for article (PubMed ID: 3062263)
21. Lovastatin decreases coenzyme Q levels in humans.
Folkers K; Langsjoen P; Willis R; Richardson P; Xia LJ; Ye CQ; Tamagawa H
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8931-4. PubMed ID: 2247468
[TBL] [Abstract][Full Text] [Related]
22. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of taurine in chronic congestive heart failure and its prospective application.
Azuma J; Sawamura A; Awata N
Jpn Circ J; 1992 Jan; 56(1):95-9. PubMed ID: 1538580
[TBL] [Abstract][Full Text] [Related]
24. Myocardial preservation by therapy with coenzyme Q10 during heart surgery.
Judy WV; Stogsdill WW; Folkers K
Clin Investig; 1993; 71(8 Suppl):S155-61. PubMed ID: 8241702
[TBL] [Abstract][Full Text] [Related]
25. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.
Mortensen SA; Vadhanavikit S; Baandrup U; Folkers K
Drugs Exp Clin Res; 1985; 11(8):581-93. PubMed ID: 3836876
[TBL] [Abstract][Full Text] [Related]
26. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.
Berman M; Erman A; Ben-Gal T; Dvir D; Georghiou GP; Stamler A; Vered Y; Vidne BA; Aravot D
Clin Cardiol; 2004 May; 27(5):295-9. PubMed ID: 15188947
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy.
Langsjoen PH; Langsjoen PH; Folkers K
Am J Cardiol; 1990 Feb; 65(7):521-3. PubMed ID: 2305693
[No Abstract] [Full Text] [Related]
28. [Therapeutic effects of coenzyme Q10 on dilated cardiomyopathy: assessment by 123I-BMIPP myocardial single photon emission computed tomography (SPECT): a multicenter trial in Osaka University Medical School Group].
Nishimura T; Hori M
Kaku Igaku; 1996 Jan; 33(1):27-32. PubMed ID: 8819712
[TBL] [Abstract][Full Text] [Related]
29. Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10.
Folkers K; Drzewoski J; Richardson PC; Ellis J; Shizukuishi S; Baker L
Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):129-40. PubMed ID: 7255868
[TBL] [Abstract][Full Text] [Related]
30. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure.
Rosenfeldt F; Hilton D; Pepe S; Krum H
Biofactors; 2003; 18(1-4):91-100. PubMed ID: 14695924
[TBL] [Abstract][Full Text] [Related]
31. Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?
Oleck S; Ventura HO
Curr Heart Fail Rep; 2016 Aug; 13(4):190-5. PubMed ID: 27333901
[TBL] [Abstract][Full Text] [Related]
32. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
Davini A; Cellerini F; Topi PL
Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
[TBL] [Abstract][Full Text] [Related]
33. Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment.
Langsjoen PH; Langsjoen PH; Folkers K
Clin Investig; 1993; 71(8 Suppl):S140-4. PubMed ID: 8241699
[TBL] [Abstract][Full Text] [Related]
34. Effects of coenzyme Q10 supplementation on diastolic function in patients with heart failure with preserved ejection fraction.
Sobirin MA; Herry Y; Sofia SN; Uddin I; Rifqi S; Tsutsui H
Drug Discov Ther; 2019; 13(1):38-46. PubMed ID: 30880321
[TBL] [Abstract][Full Text] [Related]
35. The role of coenzyme Q10 in statin-associated myopathy: a systematic review.
Marcoff L; Thompson PD
J Am Coll Cardiol; 2007 Jun; 49(23):2231-7. PubMed ID: 17560286
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.
Hofman-Bang C; Rehnqvist N; Swedberg K; Wiklund I; Aström H
J Card Fail; 1995 Mar; 1(2):101-7. PubMed ID: 9420639
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.
Lei L; Liu Y
BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783
[TBL] [Abstract][Full Text] [Related]
38. Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism.
Baruteau J; Hargreaves I; Krywawych S; Chalasani A; Land JM; Davison JE; Kwok MK; Christov G; Karimova A; Ashworth M; Anderson G; Prunty H; Rahman S; Grünewald S
Mitochondrion; 2014 Jul; 17():150-6. PubMed ID: 25010387
[TBL] [Abstract][Full Text] [Related]
39. Statin-Associated Cardiomyopathy Responds to Statin Withdrawal and Administration of Coenzyme Q
Langsjoen PH; Langsjoen JO; Langsjoen AM; Rosenfeldt F
Perm J; 2019; 23():. PubMed ID: 31496499
[TBL] [Abstract][Full Text] [Related]
40. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy.
Bhagavan HN; Chopra RK
Clin Nutr; 2005 Jun; 24(3):331-8. PubMed ID: 15896419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
